5AM Venture Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

5AM Venture Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-192,500	Closed	-$11.3M	–	29
2023 Q4	$11.3M	Hold	192,500	–	–	3%	12
2023 Q3	$8.39M	Hold	192,500	–	–	2.41%	13
2023 Q2	$6.96M	Buy	+192,500	New	+$7.93M	1.73%	17

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

5AM Venture Management's MRTX Position: Q1 2024 in Review

5AM Venture Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 192,500 shares — an estimated $11.3M sold.

5AM Venture Management first reported a position in MRTX in Q2 2023 and held it in 3 quarters. The position peaked at $11.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

5AM Venture Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
5AM Venture Management sold 192,500 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $11.3M.
5AM Venture Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
5AM Venture Management's Mirati Therapeutics, Inc. Common Stock position peaked at $11.3M in Q4 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on 5AM Venture Management's 13F filing for Q1 2024, filed 15 May 2024.